A rating of 10 puts Qualigen Therapeutics Inc (QLGN) near the bottom of the Biotechnology industry according to InvestorsObserver. Qualigen Therapeutics Inc's score of 10 means it scores higher than 10% of stocks in the industry. Qualigen Therapeutics Inc also received an overall rating of 15, putting it above 15% of all stocks. Biotechnology is ranked 30 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Qualigen Therapeutics Inc Stock Today?
Qualigen Therapeutics Inc (QLGN) stock has fallen -3.02% while the S&P 500 has risen 0.52% as of 9:46 AM on Thursday, Dec 17. QLGN is lower by -$0.11 from the previous closing price of $3.64 on volume of 158,968 shares. Over the past year the S&P 500 has risen 16.58% while QLGN is lower by -12.62%. QLGN lost -$4.68 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.
